We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Drais Pharmaceuticals and Diatos Partner to Develop and Commercialize DTS-108 for Treatment of Cancer

DTS-108 is currently ready to begin Phase I clinical trials in Europe for the treatment of patients with advanced or metastatic solid tumors.
News

In Vitro Diagnostics Industry Welcomes Pathology Report

The British In Vitro Diagnostics Association has welcomes the publication of the report of the second phase of Lord Carter’s Independent Review of Pathology Services.
News

nanoTherics Wins R&D Grant from Advantage West Midlands to Further Augment Gene Transfection Product Portfolio

The grant will enable the Company to progress development of additional novel gene transfection technologies to augment its product portfolio.
News

Galapagos and GlaxoSmithKline Expand Osteoarthritis Alliance

Galapagos receives a payment of €2 million cash from GSK for the addition of two new drug targets.
News

Mouse Studies Show Gene Therapy Method Holds Promise in Targeting Tumor Blood Vessels for Destruction

Researchers develop a method for delivering a therapeutic gene to the blood vessels of tumors in mice that damages the blood vessels and disrupts the blood flow to tumors.
News

Researchers Advance Knowledge of Little ‘Nano-Machines’ in Our Body

A discovery by Canada-U.S. biophysicists improves the understanding of ion channels, akin to little ‘nano-machines’ or ‘nano-valves’ in our body.
News

AstraZeneca and MAP Collaborate for Development and Commercialization of Unit Dose Budesonide

Unit Dose Budesonide is being developed as a potential treatment for pediatric asthma and is currently in Phase III clinical development.
News

Baxter Receives EMEA Positive Opinion for CELVAPAN, the First Cell Culture-Based Pandemic Flu Vaccine

Clinical data from a Phase III and subsequent booster study demonstrate safety, immune response and cross-protective memory.
News

Champions Biotechnology Partners to Establish Agreements for Preclinical Evaluation of Oncology Drugs

Champions Biotechnology’s Biomerk Tumorgrafts™ will be utilized by the Centocor for the preclinical evaluation of certain therapeutic agents.
News

Pfizer and Celldex Announce Amendment to ACT III Study of CDX-110 in Glioblastoma Multiforme

The ACT III study will provide a multi-center non-randomized dataset for CDX-110 in patients with newly diagnosed GBM.
Advertisement